Clinical trial
Avastin for CNV Secondary to Pattern Dystrophy
NCT00391144 · University of Trieste, Other · Unknown status
Key facts
| NCT number | NCT00391144 |
|---|---|
| Title | Avastin for CNV Secondary to Pattern Dystrophy |
| Official title | Intravitreal Avastin Injection for the Treatment of Choroidal Neovascularization Secondary to Pattern Dystrophy |
| Lead sponsor | University of Trieste, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization Secondary to Pattern Dystrophy |
| Intervention type | Procedure |
| Interventions | intravitreal triamcinolone injection of avastin (1.25 mg) |
| Enrollment | 5 |
| Start date | Jul 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Oct 23, 2006 |
| Last update posted | Oct 23, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: